정상체중 대사비만
Metabolically Obese Normal Weight(MONW)
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Metabolically obese but normal weight(MONW) syndrome is characterized, with potentially increased risks for development of the insulin resistance or metabolic syndrome despite their normal body mass index(BMI) < 25 kg/m2. Such characteristics could confer upon MONW individuals a type 2 diabetes mellitus and cardiovascular diseases(CVD) risk however, research on MONW is scarce. MONW individuals have metabolic disturbances typical of obese persons and are identified by having a high amount of visceral fat, a low BMI, a high fat mass, a low lean body mass, low insulin sensitivity, and high triglyceride concentrations. The purpose of this study is to review several markers as potential modulators in individuals displaying the "MONW". Body fat appears to be functionally comparable with a dynamic endocrine organ, producing and secreting various adipocy tokines, such as leptin, adiponectin, CRP, tumor necrosis factor(TNF-), interleukin(IL)-6, all of which play an important role in the onset of cardiovascular disease, and insulin resistance. Otherwise, physical activity and a lower inflammation state might be helped to reduce the number of persons at risk of diabetes, CVD complications, or premature mortality. We should provide a method to optimal treatments resolving the emerging public health problem to prevention of MONW by providing guideline for physical activity as an optimal treatment for the MONW Korean. Furthermore we expect to develop a new strategy to manage MONW Korean in this society in terms of reducing medical costs and enhancing public health care for uprising population with MONW.
Abstract
Metabolically obese but normal weight(MONW) syndrome is characterized, with potentially increased risks for development of the insulin resistance or metabolic syndrome despite their normal body mass index(BMI) < 25 kg/m2. Such characteristics could confer upon MONW individuals a type 2 diabetes mellitus and cardiovascular diseases(CVD) risk however, research on MONW is scarce. MONW individuals have metabolic disturbances typical of obese persons and are identified by having a high amount of visceral fat, a low BMI, a high fat mass, a low lean body mass, low insulin sensitivity, and high triglyceride concentrations. The purpose of this study is to review several markers as potential modulators in individuals displaying the "MONW". Body fat appears to be functionally comparable with a dynamic endocrine organ, producing and secreting various adipocy tokines, such as leptin, adiponectin, CRP, tumor necrosis factor(TNF-), interleukin(IL)-6, all of which play an important role in the onset of cardiovascular disease, and insulin resistance. Otherwise, physical activity and a lower inflammation state might be helped to reduce the number of persons at risk of diabetes, CVD complications, or premature mortality. We should provide a method to optimal treatments resolving the emerging public health problem to prevention of MONW by providing guideline for physical activity as an optimal treatment for the MONW Korean. Furthermore we expect to develop a new strategy to manage MONW Korean in this society in terms of reducing medical costs and enhancing public health care for uprising population with MONW.
참고문헌 (32)
- 김대중, "마른비만의 치료", 대학비만학회 춘계학술대회 연수강좌, pp.499~503 (2004)
- 보건복지부, "2007 건강투자 전략을 위한 건강정책관 핵심지표" (2007), 보건복지부
- Berg AH, "Adipose tissue, inflammation, and cardiovascular disease", Circ Res, 96, pp.939~949 (2005)
- Chung S, "Korean and Caucasian overweight premenopausal women have different relationship of body mass index to percent body fat with age", J Appl Physiol, 99(1), pp.103~107 (2005)
- Conus F, "Metabolic and behavioral characteristics of metabolically obese but norma-weight women", J Clin Endocrionol Metab, 89, pp.5013~5020 (2004)
- Conus F, "Characteristics of metabolically obese normal weight(MONW) subjects", Appl Physiol Nutr Metab, 32, pp.4~12 (2007)
- Dvorak RV, "Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women", Diabetes, 48, pp.2210~2214 (1999)
- Fu Y, "Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation", J Lipid Res, 46(7), pp.1369~1379 (2005)
- Greenberg AS, "Obesity and the role of adipose tissue in inflammation and metabolism", Am J Clin Nutr, 83, pp.461S~465S (2006)
- Haffner SM, "Abdominal adiposity and cardiometabolic risk: Do we have all the answers?", Am J Med, 120(1), pp.S10~S16 (2007)
- Hollenbeck C, "Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance", J Clin Endocrinol Metab, 64(6), pp.1169~1173 (1987)
- Homma Y, "Predictors of atherosclerosis", J Atheroscler Thromb, 11, pp.265~270 (2004)
- Karelis AD, "The metabolically healthy but obese individual presents a favorable inflammation profile", J Clin Endocrinol Metab, 90(7), pp.4145~4150 (2005)
- Katsuki A, "Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance", Diabetes Care, 26, pp.2341~2344 (2003)
- Katsuki A, "Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance", Diabetes Care, 26, pp.2964~2965 (2003)
- Katsuki A, "Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal weight men", Diabetes Care, 27, pp.631~632 (2004)
- Katsuki A, "Quantitative insulin sensitivity check index is a useful indicator of insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance", Endocr J, 52, pp.253~257 (2005)
- Lemieux I, "Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity", Arterioscler Thromb Vasc Biol, 21, pp.961~967 (2001)
- Meigs JB, "Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease", J Clin Endocrinol Metab, 91, pp.2906~2912 (2006)
- Mohamed-Ali V, "Adipose tissue as an endocrine and paracrine organ", Int J Obes Relat Metab Disord, 22(12), pp.1145~1158 (1998)
- Molero-Conejo E, "Lean adolescents with increased risk for metabolic syndrome", Arch Latinoam Nutr, 53, pp.39~43 (2003)
- Pedersen, "Exercise and cytokines with particular focus on muscle-derived IL-6", Exerc Immunol Rev, 7, pp.18~31 (2001)
- Puglish MJ, "Modulation of C-reactive protein, tumor necrosis factor-a, and adiponectin by diet, exercise, and weight loss", J Nutrition, 138, pp.2293~2296 (2008)
- Ridker PM, "High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease", Circulation, 103, pp.1813~1818 (2001)
- Rokling-Andersen MH, "Effects of long-term exercise and diet intervention on plasma adipokine concentations", Am J Clin Nutr, 86, pp.1293~1301 (2007)
- Rosenson RS, "Statin use in acute coronary syndromes: cellular mechanisms and clinical evidence", Curr Opin Lipidol, 13, pp.625~630 (2002)
- Ruderman NB, "The "metabolicallyobese", normal-weight induvidual", Am J Clin Nutr, 34, pp.1617~1621 (1981)
- Ruderman N, "The metabolically obese, normal-weight individual revisited", Diabetes, 47, pp.6699~6713 (1998)
- Shinozaki K, "Molecular mechanisms of impaired endothelial function associated with insulin resistance", Curr Drug Targets Cardiovasc Haematol Disord, 4, pp.1~11 (2004)
- Sowers JR, "Obesity as a cardiovascular risk factor", Am J Med, 115(8A), pp.37S~41S (2003)
- Sowers JR, "Endocrine functions of adipose tissue: focus on adiponectin", Clin Cornerstone, 9(1), pp.32~40 (2008)
- St-Onge MP, "Metabolic syndrome in normal-weight Americans. New definition of the of the metabolly obese, normal-weight individual", Diabetes Care, 27, pp.2222~2228 (2004)